title: A dimorphic blast population demonstrates Philadelphia-positive mixed phenotype acute leukaemia.
authors.affiliation: 1Laboratory Haematology Department, The Alfred Hospital, Melbourne 2Victorian Cancer Cytogenetics Service, St Vincent's Hospital Melbourne, Fitzroy, Vic, Australia.
authors.forename: Victoria Y
authors.initials: VY
authors.lastname: Ling
authors.forename: Meaghan
authors.initials: M
authors.lastname: Wall
authors.forename: Amanda
authors.initials: A
authors.lastname: Davis
authors.forename: Malgorzata
authors.initials: M
authors.lastname: Gorniak
authors.forename: George
authors.initials: G
authors.lastname: Grigoriadis
mesh_terms: D000328:Adult; D001549:Benzamides / Q000627:therapeutic use*; D001707:Biopsy, Needle; D001853:Bone Marrow / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D005434:Flow Cytometry; D042381:Granulocyte Precursor Cells; D006801:Humans; D000068877:Imatinib Mesylate; D017404:In Situ Hybridization, Fluorescence; D060828:Induction Chemotherapy; D007621:Karyotyping; D015456:Leukemia, Biphenotypic, Acute / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D010641:Phenotype; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use*; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate